Navidea Biopharmaceuticals Announces 50th Participant Enrolled in the Company s Phase 3 Trial in Rheumatoid Arthritis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
15.08.2022 - Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the second quarter and .
Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace